Home · Compare

Mayukh Sukhatme vs Nicole LaBrosse

💰 How does your salary compare?

See how you rank against the world's top executives — free, instant, SEC-backed data

Mayukh Sukhatme earned $247.3M (5401%) more than Nicole LaBrosse in their most recent fiscal years on record.

Mayukh SukhatmeNicole LaBrosse

CompanyRoivant SciencesHalozyme Therapeutics

TitlePresident and Chief Investment OfficerExecutive Officer

IndustryHealthcareHealthcare

Fiscal YearFY2024FY2025

Total Pay$251.9M$4.6M

Base Salary$550,000$604,188

Stock Awards$170.2M$3.5M

Bonus$81.1M—

Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.

← Back to database · Mayukh Sukhatme's full profile · Nicole LaBrosse's full profile

ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy